nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype
|
Dharmadhikari, Bhushan |
|
2018 |
67 |
6 |
p. 893-905 |
artikel |
2 |
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions
|
Mahaweni, Niken M. |
|
2018 |
67 |
6 |
p. 861-872 |
artikel |
3 |
Defective HLA class I antigen processing machinery in cancer
|
Cai, Lei |
|
2018 |
67 |
6 |
p. 999-1009 |
artikel |
4 |
Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals
|
Arranz-Nicolás, Javier |
|
2018 |
67 |
6 |
p. 965-980 |
artikel |
5 |
Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanoma
|
van den Brom, Rob R. H. |
|
2018 |
67 |
6 |
p. 925-933 |
artikel |
6 |
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016
|
Russo, Vincenzo |
|
2017 |
67 |
6 |
p. 1023-1030 |
artikel |
7 |
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination
|
Takeda, Kazuyoshi |
|
2018 |
67 |
6 |
p. 949-964 |
artikel |
8 |
Rational combinations of in vivo cancer antigen priming and adoptive T-cell therapy mobilize immune and clinical responses in terminal cancers
|
Ruan, Qing Zhao |
|
2018 |
67 |
6 |
p. 907-915 |
artikel |
9 |
Rituximab as a therapeutic option for patients with advanced melanoma
|
Winkler, Julia K. |
|
2018 |
67 |
6 |
p. 917-924 |
artikel |
10 |
T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns
|
Callahan, Blake M. |
|
2018 |
67 |
6 |
p. 885-892 |
artikel |
11 |
T cell responses to tumor: how dominant assumptions on immune activity led to a neglect of pathological functions, and how evolutionary considerations can help identify testable hypotheses for improving immunotherapy
|
Kallikourdis, Marinos |
|
2018 |
67 |
6 |
p. 989-998 |
artikel |
12 |
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy
|
Anichini, Andrea |
|
2018 |
67 |
6 |
p. 1011-1022 |
artikel |
13 |
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma
|
Kropp, Korbinian N. |
|
2018 |
67 |
6 |
p. 935-947 |
artikel |
14 |
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies
|
Petitprez, Florent |
|
2017 |
67 |
6 |
p. 981-988 |
artikel |
15 |
Tumor-associated myeloid cells promote tumorigenesis of non-tumorigenic human and murine prostatic epithelial cell lines
|
Sass, Stephanie N. |
|
2018 |
67 |
6 |
p. 873-883 |
artikel |